Opportunity Information: Apply for CDC RFA GH19 1934
This funding opportunity (CDC RFA GH19-1934) is a PEPFAR-supported cooperative agreement from the U.S. Centers for Disease Control and Prevention (CDC), under the Department of Health and Human Services, focused on expanding and strengthening comprehensive HIV/AIDS services in the Democratic Republic of Congo, specifically in selected Health Zones in Kinshasa province. The core purpose is to accelerate progress toward HIV epidemic control by improving how HIV prevention, testing, treatment, and related support services are delivered, coordinated, and monitored in targeted areas where intensified efforts can produce measurable population-level impact. The program is designed to push the HIV response beyond routine service delivery by emphasizing strategic targeting, rapid linkage to care, strong retention and viral suppression outcomes, and consistent use of high-quality data to guide decisions.
The NOFO centers on finding more people living with HIV (PLHIV) and getting them effectively into care, with a strong focus on evidence-based HIV testing approaches. A key strategy highlighted is targeted testing among eligible contacts of HIV-positive index cases, which typically involves identifying and offering testing to sexual partners and other at-risk contacts of individuals newly diagnosed or known to be living with HIV, in a manner that is safe, confidential, and respectful. By prioritizing higher-yield testing approaches rather than broad, untargeted testing, the project aims to diagnose people earlier and close gaps in case-finding, particularly among populations that may be missed by facility-only testing models.
Beyond testing, the opportunity describes a fully integrated service package that links prevention, clinical care, and community-based support. This includes HIV prevention services and outreach, with special attention to community platforms such as Orphans and Vulnerable Children (OVC) programs. OVC services are framed as an important channel for community engagement because they often reach households experiencing health, social, and economic vulnerabilities that can affect HIV risk, access to care, and treatment adherence. By leveraging OVC-related outreach, the program can strengthen prevention messaging, facilitate referrals for testing, and support retention efforts for clients and families affected by HIV.
The NOFO also emphasizes TB/HIV integration, covering prevention, diagnosis, and treatment services for tuberculosis among people living with HIV and those at risk. Since TB remains a leading cause of illness and death among PLHIV in many settings, integrating TB screening, preventive therapy where appropriate, and prompt TB diagnosis and treatment within HIV services is treated as a necessary component of epidemic control rather than a separate activity. The opportunity likewise includes Prevention of Mother-to-Child Transmission (PMTCT) services, aimed at reducing HIV transmission during pregnancy, delivery, and breastfeeding. Importantly, PMTCT efforts are meant to reach both the general population and key populations (KP), recognizing that certain groups may face additional barriers to antenatal care, HIV testing, and sustained treatment.
Laboratory support and strategic information (SI) are presented as foundational to the entire program. Laboratory capacity is critical for accurate diagnosis and for monitoring treatment success, especially through viral load testing, which is central to determining whether clients are achieving viral suppression and whether programs are on track for epidemic control. Strategic information refers to the systems and practices used to collect, validate, analyze, and use HIV program data. The NOFO explicitly calls for improving data quality and promoting data use for decision-making, which typically means strengthening routine reporting, reducing missing or inconsistent records, improving patient tracking across services, and using performance data to identify gaps such as low linkage rates, weak retention, or delayed viral load monitoring.
A defining feature of the award is that it is a cooperative agreement, meaning CDC expects substantial involvement beyond standard grant oversight. In practice, this often translates into close collaboration with CDC technical staff on planning, implementation choices, monitoring, and program improvement. The recipient is expected to provide both direct support and technical assistance to accelerate the HIV service delivery cascade, meaning the full pathway from HIV testing and diagnosis to linkage to treatment, retention in care, and viral suppression. The program also calls for a stigma-free approach, signaling that service delivery should actively reduce stigma and discrimination that can discourage people from seeking testing or staying in care, especially for key populations and others who may face social exclusion.
Capacity-building for local health leadership is another major objective. The recipient is expected to work closely with the Ministry of Health (MOH) to strengthen the technical capacity of provincial teams and Health Zone teams. This implies hands-on support for planning, supervision, quality improvement, and data review processes at decentralized levels, so that local health authorities can more effectively manage HIV services over time. The NOFO also anticipates a meaningful role for capable community organizations, particularly in boosting demand for services, improving uptake of HIV testing and prevention options, strengthening linkage to treatment after diagnosis, and supporting retention so clients remain engaged in care and reach viral suppression.
In terms of basic funding details, the opportunity was published by CDC’s Center for Global Health (CGH) as a discretionary funding opportunity in the health category, tied to CFDA 93.067. Eligibility is listed as unrestricted, meaning it is open to many entity types as long as any specific eligibility clarifications in the full notice are met. The anticipated award structure was a single award (expected awards: 1) with an award ceiling of $3,000,000. The NOFO was created on August 3, 2018, with an original application closing date of October 2, 2018, and electronic submissions due by 11:59 p.m. Eastern Time on the deadline.
Overall, the grant opportunity is aimed at helping Kinshasa move faster toward HIV epidemic control by combining targeted case-finding, integrated TB/HIV and PMTCT services, community-based engagement including OVC platforms, stronger laboratory and data systems, and intensive technical collaboration with the MOH and local Health Zone structures. The long-term framing is ambitious and explicit: contribute to the elimination of HIV as a public health threat by 2030 by improving the performance and coverage of the full HIV service cascade in selected Kinshasa Health Zones.Apply for CDC RFA GH19 1934
- The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Enhance Population Access to Comprehensive HIV/AIDS Services in Order to Achieve HIV/AIDS Epidemic Control in the Democratic Republic of Congo (DRC), Specifically in Kinshasa under the President's Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
- This funding opportunity was created on Aug 03, 2018.
- Applicants must submit their applications by Oct 02, 2018 Electronically submitted applications must be submitted no later than 1159 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $3,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is CDC RFA GH19-1934?
CDC RFA GH19-1934 is a PEPFAR-supported cooperative agreement funding opportunity from the U.S. Centers for Disease Control and Prevention (CDC), under the U.S. Department of Health and Human Services. It focuses on expanding and strengthening comprehensive HIV/AIDS services in the Democratic Republic of Congo (DRC), specifically in selected Health Zones in Kinshasa province.
What is the main goal of this funding opportunity?
The core goal is to accelerate progress toward HIV epidemic control in targeted areas by improving how HIV prevention, testing, treatment, and related support services are delivered, coordinated, and monitored. The opportunity emphasizes measurable population-level impact in selected Kinshasa Health Zones where intensified efforts can close gaps across the HIV service cascade.
Which geographic area does the program focus on?
The program targets selected Health Zones in Kinshasa province in the Democratic Republic of Congo.
What is meant by “HIV epidemic control” in this program’s context?
In this NOFO, epidemic control is pursued by strengthening the full HIV cascade: finding people living with HIV (PLHIV), linking them rapidly to care, retaining them in treatment, and achieving viral suppression, supported by strong laboratory systems and high-quality data for decision-making.
What types of HIV services are expected to be strengthened?
The opportunity describes a comprehensive, integrated package that includes HIV prevention, HIV testing, linkage to treatment after diagnosis, retention support, and viral load monitoring to improve viral suppression outcomes. It also includes TB/HIV integration and Prevention of Mother-to-Child Transmission (PMTCT) services.
How does the NOFO prioritize HIV testing?
The NOFO emphasizes evidence-based HIV testing approaches that focus on finding undiagnosed PLHIV efficiently. Rather than relying on broad untargeted testing, it highlights higher-yield approaches designed to close case-finding gaps, including strategies that can reach people missed by facility-only testing models.
What is “targeted testing among eligible contacts of HIV-positive index cases”?
This refers to identifying and offering HIV testing to sexual partners and other at-risk contacts of individuals who are newly diagnosed or known to be living with HIV. The approach is described as needing to be safe, confidential, and respectful, and is intended to increase case-finding yield by focusing on people with higher likelihood of exposure.
Why does the program emphasize rapid linkage to care?
The opportunity is designed to move beyond routine service delivery by accelerating movement from HIV diagnosis to treatment enrollment. Rapid linkage reduces delays that can lead to loss to follow-up and supports stronger retention and viral suppression outcomes over time.
What does the NOFO say about retention and viral suppression?
Retention and viral suppression are central performance priorities. The program expects strengthened service delivery and monitoring so that clients stay engaged in care and reach viral suppression, using laboratory capacity (including viral load testing) and data systems to track progress and identify gaps.
How are community-based platforms, including OVC programs, incorporated?
The NOFO highlights Orphans and Vulnerable Children (OVC) programs as an important community engagement channel. Because OVC services often reach households facing social and economic vulnerabilities that affect HIV risk and treatment adherence, the program aims to leverage OVC-related outreach to strengthen prevention messaging, facilitate referrals for HIV testing, and support retention for clients and affected families.
What does TB/HIV integration include under this opportunity?
TB/HIV integration is treated as a necessary component of epidemic control. It includes prevention, screening/diagnosis, and treatment services for tuberculosis among PLHIV and those at risk, including integrating TB activities within HIV services to reduce TB-related illness and death.
What PMTCT activities are included?
The NOFO includes Prevention of Mother-to-Child Transmission (PMTCT) services aimed at reducing HIV transmission during pregnancy, delivery, and breastfeeding. PMTCT efforts are intended to reach both the general population and key populations, recognizing that some groups face additional barriers to antenatal care, testing, and sustained treatment.
What are “key populations (KP)” in the context of this NOFO?
The NOFO references key populations (KP) in relation to ensuring PMTCT and other HIV services reach groups that may experience additional barriers to care, stigma, or exclusion. The opportunity underscores the need for a stigma-free approach, especially for populations that may be more affected by discrimination.
Why is laboratory support considered foundational in this program?
Laboratory capacity supports accurate HIV diagnosis and treatment monitoring. The NOFO specifically emphasizes viral load testing as central to determining whether clients are virally suppressed and whether programs are on track toward epidemic control.
What does “strategic information (SI)” mean here?
Strategic information (SI) refers to the systems and practices used to collect, validate, analyze, and use HIV program data. The NOFO calls for improving data quality and promoting routine data use for decision-making, including strengthening reporting, reducing missing or inconsistent records, improving patient tracking across services, and using performance data to identify and address gaps (such as low linkage, weak retention, or delayed viral load monitoring).
What makes this award a “cooperative agreement” rather than a standard grant?
This opportunity is a cooperative agreement, meaning CDC anticipates substantial involvement beyond standard grant oversight. The recipient is expected to collaborate closely with CDC technical staff on planning, implementation decisions, monitoring, and program improvement.
What kind of support is the recipient expected to provide?
The recipient is expected to provide both direct support and technical assistance to strengthen the HIV service delivery cascade in targeted areas. This includes support spanning testing, linkage to care, retention, and viral suppression, with integrated TB/HIV and PMTCT services, and strengthened laboratory and data systems.
What does the NOFO say about stigma and discrimination?
The opportunity calls for a stigma-free approach. This indicates that service delivery should actively reduce stigma and discrimination that can deter people from seeking HIV testing or staying in care, including among key populations and others who may experience social exclusion.
How is the Ministry of Health (MOH) involved?
Capacity-building for local health leadership is a major objective. The recipient is expected to work closely with the MOH to strengthen the technical capacity of provincial teams and Health Zone teams, supporting planning, supervision, quality improvement, and data review processes at decentralized levels.
What role do local community organizations play?
The NOFO anticipates a meaningful role for capable community organizations in increasing demand for services, improving uptake of HIV testing and prevention options, strengthening linkage to treatment after diagnosis, and supporting retention so clients remain in care and reach viral suppression.
Who is eligible to apply?
Eligibility is listed as unrestricted, meaning the opportunity is open to many entity types, as long as any specific eligibility clarifications in the full notice are met.
Which CDC center published this opportunity?
The opportunity was published by CDC’s Center for Global Health (CGH).
What is the CFDA number associated with this funding?
The opportunity is tied to CFDA 93.067.
How many awards were expected?
The NOFO anticipated a single award (expected awards: 1).
What is the award ceiling for this opportunity?
The award ceiling is $3,000,000.
When was the NOFO created and when were applications due?
The NOFO was created on August 3, 2018. The original application closing date was October 2, 2018, with electronic submissions due by 11:59 p.m. Eastern Time on the deadline.
What is the long-term objective referenced by the opportunity?
The long-term framing is to contribute to eliminating HIV as a public health threat by 2030, by improving performance and coverage of the full HIV service cascade in selected Health Zones in Kinshasa.
What does “selected Health Zones” imply for implementation?
Based on the NOFO description, activities are intended to be concentrated in specific Health Zones within Kinshasa province where intensified interventions can produce measurable, population-level impact, rather than being spread broadly without strategic targeting.
Browse more opportunities from the same category: Health
Next opportunity: Support Park Youth Preservation Crew for Painting Exterior of 492 Auburn
Previous opportunity: OSERS-OSEP: National Technical Assistance Center on Positive Behavioral Interventions and Supports CFDA Number 84.326S
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH19 1934
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH19 1934) also looked into and applied for these:
| Funding Opportunity |
|---|
| Initiative for TB/HIV Program Collaboration and Service Integration in the Central America Region under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH19 1947 Funding Number: CDC RFA GH19 1947 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $1,500,000 |
| Develop, Implement, and Sustain High Quality Comprehensive HIV Cascade Activities for Children, Adolescents, and Adults in Facility and Community Based Settings in Cameroon under the President`s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH19 1916 Funding Number: CDC RFA GH19 1916 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $34,000,000 |
| Innovating for HIV Impact: The South African HIV Innovations Accelerator Apply for SA HIV INNOVATIONS 2018 Funding Number: SA HIV INNOVATIONS 2018 Agency: Agency for International Development Category: Health Funding Amount: $1,500,000 |
| State Primary Care Offices Apply for HRSA 19 005 Funding Number: HRSA 19 005 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Service Area Competition Apply for HRSA 19 015 Funding Number: HRSA 19 015 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Implementing Evidence-Based Prevention Interventions for Key and Priority Populations in the Republic of Rwanda under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH19 1940 Funding Number: CDC RFA GH19 1940 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $2,514,175 |
| Strengthening the Ministry of Health's Capacity to Sustain and Expand Quality HIV Prevention, Care and Treatment Services for People Living with HIV in Vietnam through Focused Direct Service Support, Technical Assistance, and Innovations under P Apply for CDC RFA GH19 1904 Funding Number: CDC RFA GH19 1904 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $6,000,000 |
| Strengthening the Health System Capacity to Implement HIV Prevention, Care, and Treatment Services in the Republic of South Africa under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH19 1920 Funding Number: CDC RFA GH19 1920 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $30,000,000 |
| Strengthening Vietnam's Indigenous Technical Assistance Capacity and Systems through Support for HIV/AIDS Clinical Mentorship and Health System Strengthening under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH19 1930 Funding Number: CDC RFA GH19 1930 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $1,500,000 |
| Accelerating the Coordination of Health Policy and Strategies for HIV/AIDS Treatment Services through the Tanzania Commission for AIDS (TACAIDS) in the United Republic of Tanzania under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH19 1918 Funding Number: CDC RFA GH19 1918 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $500,000 |
| Novel and Innovative Tools to Facilitate Identification, Tracking, Manipulation, and Analysis of Glycans and their Functions (U01 Clinical Trial Not Allowed) Apply for RFA RM 18 036 Funding Number: RFA RM 18 036 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $320,000 |
| Accelerating the Implementation of Health Policy and Strategies for HIV/AIDS Treatment Services through the President's Office - Regional Administration and Local Government (PO-RALG) in the United Republic of Tanzania under PEPFAR Apply for CDC RFA GH19 1956 Funding Number: CDC RFA GH19 1956 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $500,000 |
| Ensuring High Quality in Mentor Mother Strategy Implementation: Helping Mothers Eliminate Pediatric HIV in Mozambique under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH19 1903 Funding Number: CDC RFA GH19 1903 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $5,000,000 |
| Pediatric Immunotherapy Discovery and Development Network (PI-DDN)(U54 - Clinical Trial Not Allowed) Apply for RFA CA 19 003 Funding Number: RFA CA 19 003 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $1,600,000 |
| Strengthening the Public Health System in the U.S.-Affiliated Pacific Islands Apply for CDC RFA OT16 16010301SUPP18 Funding Number: CDC RFA OT16 16010301SUPP18 Agency: Department of Health and Human Services, Centers for Disease Control - OSTLTS Category: Health Funding Amount: $1,000,000 |
| Strategic Information Support Across Countries under the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria and under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH19 1951 Funding Number: CDC RFA GH19 1951 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $10,000,000 |
| Epidemiology Program for American Indian/Alaska Native Tribes and Urban Indian Communities, Cancer Activities Apply for HHS 2018 IHS EPI 0001 Funding Number: HHS 2018 IHS EPI 0001 Agency: Department of Health and Human Services, Indian Health Service Category: Health Funding Amount: $220,000 |
| Epidemiology Program for American Indian/Alaska Native Tribes and Urban Indian Communities, Rocky Mountain Spotted Fever Apply for HHS 2018 IHS EPI 0002 Funding Number: HHS 2018 IHS EPI 0002 Agency: Department of Health and Human Services, Indian Health Service Category: Health Funding Amount: $300,000 |
| Strengthen Capacity of South African Government's Department of Health and Implementing Partners to Deliver Quality Differentiated, Advanced Clinical Care for Unstable HIV and TB/HIV Patients in the Republic of South Africa under PEPFAR Apply for CDC RFA GH19 1923 Funding Number: CDC RFA GH19 1923 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $5,000,000 |
| Supporting Counties and Other Indigenous Health Management Institutions to Bridge Skill Gaps Among Health Care Workforce Necessary for HIV Epidemic Control in Kenya under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH19 1929 Funding Number: CDC RFA GH19 1929 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $689,776 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH19 1934", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.